A customized pigmentation SNP array identifies a novel SNP associated with

melanoma predisposition in the SLC45A2 gene.

Ibarrola-Villava M, Fernandez LP, Alonso S, Boyano MD, Pea-Chilet M, Pita G,
Aviles JA, Mayor M, Gomez-Fernandez C, Casado B, Martin-Gonzalez M, Izagirre N,
De la Rua C, Asumendi A, Perez-Yarza G, Arroyo-Berdugo Y, Boldo E, Lozoya R,
Torrijos-Aguilar A, Pitarch A, Pitarch G, Sanchez-Motilla JM, Valcuende-Cavero F,
Tomas-Cabedo G, Perez-Pastor G, Diaz-Perez JL, Gardeazabal J, Martinez de Lizarduy
I, Sanchez-Diez A, Valdes C, Pizarro A, Casado M, Carretero G, Botella-Estrada R,
Nagore E, Lazaro P, Lluch A, Benitez J, Martinez-Cadenas C, Ribas G.
PLoS One. 2011 Apr 29;6(4):e19271. doi: 10.1371/journal.pone.0019271.
Cell-centric view of apoptosis and apoptotic cell death-inducing antitumoral strategies.
Apraiz A, Boyano MD, Asumendi A.
Cancers (Basel). 2011 Mar 3;3(1):1042-80. doi: 10.3390/cancers3011042.
Plasma membrane and nuclear envelope integrity during the blebbing stage of
apoptosis: a time-lapse study.
Andrade R, Crisol L, Prado R, Boyano MD, Arluzea J, Archaga J.
Biol Cell. 2009 Oct 12;102(1):25-35. doi: 10.1042/BC20090077.
Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma.
Nieto-Rementera N, Prez-Yarza G, Boyano MD, Apraiz A, Izu R, Daz-Prez JL,
Asumendi A.
Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub
2008 Nov 25.
Imprinting of mammalian male gametes is gene specific and does not occur at a single
stage of differentiation.
Boyano MD, Andollo N, Zalduendo MM, Archaga J.
Int J Dev Biol. 2008;52(8):1105-11. doi: 10.1387/ijdb.072284mb.
4-HPR-mediated leukemia cell cytotoxicity is triggered by ceramide-induced
mitochondrial oxidative stress and is regulated downstream by Bcl-2.
Morales MC, Prez-Yarza G, Rementera NN, Boyano MD, Apraiz A, Gmez-Muoz
A, Prez-Andrs E, Asumendi A.
Free Radic Res. 2007 May;41(5):591-601.

Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the

antineoplasic agent N-(4-hydroxyphenyl) retinamide.
Morales MC, Prez-Yarza G, Nieto-Rementeria N, Boyano MD, Jangi M, Atencia R,
Asumendi A.
Anticancer Res. 2005 May-Jun;25(3B):1945-51.
Structural and functional preservation of specific sequences of DNA and mRNA in
apoptotic bodies from ES cells.
Andollo N, Boyano MD, Andrade R, Zalduendo MM, Eguizabal C, Asumendi A,
Arlucea J, Archaga J.
Apoptosis. 2005 Mar;10(2):417-28.
Effect of IL-2 and IL-6 on parameters related to metastatic activity in a murine
melanoma.
Garca de Galdeano A, Cruz-Conde JC, Boyano MD, Garca-Vzquez MD, Caavate
ML.
Pathobiology. 2001;69(4):230-6.
Interleukin-2 enhances the growth of human melanoma cells derived form primary but
not from metastatic tumours.
Garca-Vzquez MD, Boyano MD, Caavate ML, Gardeazabal J, de Galdeano AG,
Lpez-Michelena T, Ratn JA, Izu R, Daz-Ramn JL, Daz-Prez JL.
Eur Cytokine Netw. 2000 Dec;11(4):654-61.
Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10
serum levels in patients with melanoma.
Boyano MD, Garcia-Vzquez MD, Lpez-Michelena T, Gardeazabal J, Bilbao J,
Caavate ML, Galdeano AG, Izu R, Daz-Ramn L, Raton JA, Daz-Prez JL.
Br J Cancer. 2000 Oct;83(7):847-52.
The role of cleavage of cell structures during apoptosis.
Asumendi A, Andollo N, Boyano MD, Hilario E, Perez-Yarza G, Atencia R, Arechaga
J, Garca-Sanz M.
Cell Mol Biol (Noisy-le-grand). 2000 Feb;46(1):1-11.
Cyclosporin A upmodulates the alpha-subunit of the interleukin-2 receptor and the
metastatic ability of murine B16F10 melanoma cells.

Boyano MD, de Galdeano AG, Garca-Vzquez MD, Alvarez A, Luz Caavate M.

Invasion Metastasis. 1998-1999;18(3):122-33.
Effect induced by interleukin-1 on the behaviour of B16F10 melanoma cells.
De Galdeano AG, Boyano D, Caavate L.
Oncol Rep. 1999 Jan-Feb;6(1):225-8.
Involvement of interleukin-6 in the biology and metastatic activity of B16F10
melanoma cells.
Garca de Galdeano, Boyano D, Smith-Zubiaga I, Alvarez A, Cantn I, Caavate L.
Eur Cytokine Netw. 1998 Jun;9(2):187-92.
Serum-soluble IL-2 receptor and IL-6 levels in patients with melanoma.
Boyano MD, Garca-Vzquez MD, Gardeazabal J, Garca de Galdeano A, SmithZubiaga I, Caavate ML, Raton JA, Bilbao I, Daz-Prez JL.
Oncology. 1997 Sep-Oct;54(5):400-6.
Parental chromosome-specific chromatin conformation in the imprinted U2af1-rs1 gene
in the mouse.
Feil R, Boyano MD, Allen ND, Kelsey G.
J Biol Chem. 1997 Aug 15;272(33):20893-900.
IL-2 treatment of B16F10 melanoma cells stimulates metastatic colonization in the
liver.
Boyano MD, Garcia de Galdeano A, Smith-Zubiaga I, Caavate ML.
Anticancer Res. 1997 Mar-Apr;17(2A):1135-41.
Serum interleukin-6 levels in patients with melanoma.
Garca-Vzquez MD, Daz-Prez JL, Gardeazabal J, Caavate ML, Garca de Galdeano
A, Smith-Zubiaga I, Boyano MD.
Int J Dev Biol. 1996;Suppl 1:305S-306S. No abstract available.
Expression of IL-2 receptor beta-chain in B16 melanoma cells.
Garcia De Galdeano A, Boyano MD, Ayesta A, Alvarez MA, Smith-Zubiaga I, GarciaVazquez MD, Caavate ML.

Int J Dev Biol. 1996;Suppl 1:301S-302S. No abstract available.

B16F10 murine melanoma cells express interleukin-2 and a functional interleukin-2
receptor.
Garca de Galdeano A, Boyano MD, Smith-Zubiaga I, Caavate ML.
Tumour Biol. 1996;17(3):155-67.
Enhancement of Ia antigen expression and nonproliferating cells correlates with
metastatic capacity.
Boyano MD, Smith-Zubiaga I, Alvarez A, Garca de Galdeano A, Barber-Guillem E,
Caavate ML.
Pathobiology. 1994;62(4):186-93.
Oncogene and MDR1 gene expression in rat rhabdomyosarcoma sublines of different
metastatic potential.
Hanania N, Boyano MD, Mangin C, Poupon MF.
Anticancer Res. 1991 Jan-Feb;11(1):473-80.
Estimating anatomical-functional position coordinates in liver tissue.
Barber-Guillem E, Alonso-Varona A, Boyano MD, Vidal-Vanaclocha F.
Anat Rec. 1990 Nov;228(3):267-76.
Coincident implantation, growth and interaction sites within the liver of cancer and
reactive hematopoietic cells.
Vidal-Vanaclocha F, Alonso-Varona A, Ayala R, Boyano MD, Barber-Guillem E.
Int J Cancer. 1990 Aug 15;46(2):267-71.